Prenatal and Newborn Genetic Testing Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, Italy, UK, Spain, China, India, Japan, South Korea, Australia, Singapore, Argentina, Brazil, Mexico, South Africa, U.A.E, Saudi Arabia), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024
Report ID: GMI1906
Prenatal and Newborn Genetic Testing Market size is projected to experience significant growth from 2017 to 2024.
Growing occurrence of the genetic diseases is the major factor driving global prenatal and newborn genetic testing market. The demand for prenatal and newborn genetic testing is increasing as expecting parents seek to test and identify genomic abnormalities. Rising R&D activities for proteomics and genomics coupled with technological advancement will propel industry growth over the forecast period.
Advancing genome profiling technology including TaqMan PCR coupled with advances in fetal cell research are boosting the business growth. There is widespread existence of public as well as private organizations that support the research studies for genomic testing. For instance, the Max Planck Institute for molecular genetics and National Human Genome Research Institute (NHGRI) capitalizes, promotes and conducts genomic research.
Increasing awareness level in pregnant women for testing and screening about chromosomal abnormalities in fetus provides immense growth opportunities. The major challenge declining the industry growth is decreasing fertility rates globally eventually decreasing in pregnancy numbers and fertility rates, negatively impacting the market. As per, United Nations Department of Economic and Social Affairs, the Population Division analyzed the world fertility patterns in 2015 were 2.5 kids per woman worldwide.
According to the government of Western Australia Department of Health, approximately 5% of newborns in the Western Australia have birth defect. It is the major factor boosting the prenatal and newborn genetic testing market size. Several procedures are carried out in order to screen the birth defects such as, quad marker screen (Quad), serum integrated prenatal screen (SIPS), complete second trimester ultrasound for prenatal genomic screening, and integrated prenatal screen (IPS). Availability of these tests and increasing awareness among the pregnant women regarding these tests are propelling business growth.
Diagnostics techniques accounted for major share in technology segment owing to wide-ranging applications in detection of the birth defects through genomic testing that include, array-comparative genetic hybridization (aCGH), fluorescence in-situ hybridization (FISH), and polymerase chain reaction (PCR). PCR is the most preferred and widely used technique due to its indispensable applications in medical and biological research along with capability to diagnose inherited diseases with functional analysis in genes.
U.S. prenatal and newborn genetic testing market will witness substantial growth owing to existence of advanced technology that include real time and multiplex PCR techniques coupled with favorable government policies. Structure for screening programs including postnatal, prenatal, selective or universal differs within the U.S. advancement in molecular testing enabled diagnosis of intricate sickling disorders and thalassemia thereby, fueling business growth over the forecast timeframe.
India and China prenatal and newborn genetic testing market is growing significantly due to improving healthcare facilities, increasing awareness about genetic disorders, thereby rising demand for screening techniques. Moreover, developing activities and government supporting policies coupled with growing economic progress are further boosting industry growth.
Some of the industry players include, Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics, Quest Diagnostic, Bio-Rad, AutoGenomics, Bio-Rad, Abbott, Cepheid, EKF Diagnostics, Natera, Agilent Technologies, Illumina, Ariosa Diagnostics, Sequenom, and Laboratory Corporation of America Holdings. The industry players focus on strategic alliances, mergers, partnership and acquisitions for upsurge in firm growth. For instance, in September 2016, AutoGenomics and WuXi AppTec Lab testing division formed strategic partnership for introduction of advanced molecular technology of diagnosis to China. This will provide the company with regional expansion for its products.
What Information does this report contain?
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security